Curis Inc. Implements 1-for-20 Reverse Stock Split to Maintain Nasdaq Listing
CRIS has more than doubled off its 52-week low of $0.181.
Summary
Curis Inc. has officially implemented a 1-for-20 reverse stock split, effective today, with split-adjusted trading beginning July 6, 2026, a critical step to regain Nasdaq compliance.
Key Events · Corporate Governance and Compliance · CRIS
-
Reverse Stock Split Implemented
Curis Inc. filed a certificate of amendment to its Restated Certificate of Incorporation, officially effecting a 1-for-20 reverse stock split as of July 2, 2026. Trading on a split-adjusted basis will commence on July 6, 2026.
-
Nasdaq Compliance Measure
This reverse stock split is a direct response to the company's delisting determination letter from Nasdaq, aiming to increase the per-share price to meet listing requirements.
-
No Change to Authorized Shares or Par Value
The reverse stock split will not alter the par value of the common stock or the total number of authorized shares of common stock. All outstanding warrants, restricted stock units, and stock options will be adjusted accordingly.
Analysis · CRIS · Life Sciences
Curis Inc. has officially executed a 1-for-20 reverse stock split by filing the necessary certificate of amendment. This action is a critical step for the company to regain compliance with Nasdaq's minimum bid price requirement, following a delisting notice received in May. While a reverse split does not change the company's fundamental value, it is a necessary measure to avoid delisting and maintain access to public capital markets, especially given the company's previously disclosed 'going concern' doubt and lack of revenue.
At the time of this filing, CRIS was trading at $0.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.5M. The 52-week trading range was $0.18 to $2.48. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.